Table S2.
B. subtilis strains used in this study
| Strain | Genotype or description | Reference or construction* |
| PY79 | Wild-type laboratory strain | (73) |
| ΔcotH | ΔcotH::kanr | pcotH::kanr → PY79 (KmR) |
| CotH-V5 (PcotH) | ΔcotH::kanr amyE::PcotG-PcotH-cotH-V5 | pJLG13-PcotG-PcotH-cotH-V5 → ΔcotH (KmR) (CmR) |
| CotHD251A-V5 (PcotH) | ΔcotH::kanr amyE::PcotG-PcotHD251A-cotH-V5 | pJLG13-PcotG-PcotH-cotHD251A-V5 → ΔcotH (KmR) (CmR) |
| CotHD251A-V5 (PcotA) | ΔcotH::kanr amyE::PcotA-PcotHD251A-cotH-V5 | pamyE::PcotA-cotHD251A-V5 → ΔcotH (KmR) (CmR) |
| CotHD251A-V5 (PcotE) | ΔcotH::kanr amyE::PcotE-PcotH-cotHD251A-V5 | pamyE::PcotE-cotHD251A-V5 → ΔcotH (KmR) (CmR) |
| CotHD251A-V5 (PgerE) | ΔcotH::kanr amyE::PgerE-PcotH-cotHD251A-V5 | pamyE::PgerE-cotHD251A-V5 → ΔcotH (KmR) (CmR) |
-
↵* Plasmid or genomic DNA used (right of the arrow) to transform an existing strain (left of the arrow) to create a new strain is listed. The drug resistance is noted in parentheses. CmR, chloramphenicol resistance; KmR, kanamycin resistance.
